Special Issue "Cancer Pains"
A special issue of Cancers (ISSN 2072-6694).
Deadline for manuscript submissions: closed (31 January 2019)
Pain is one of the most prevalent, burdensome, and feared symptoms among cancer patients. The prevalence of pain in cancer population has been estimated to be high, particularly in the advanced stage of disease. In developing countries, pain prevalence is even higher due to a late diagnosis. On the other hand chronic pain in cancer survivors affect about 1/3 of patients.
With such high figures, attention to pain should considered an institutional priority for oncology setting. While scientific evidence and effort to disseminate them through recommendations and guidelines, suboptimal management of pain persist in clinical setting, with over 80% of the world’s population being inadequately treated.
The pharmacologic treatment with analgesics is the foundation of cancer pain management. Despite the lack of significant evidence of effectiveness and potential adverse consequences, opioids are recommended as the mainstay of treatment for cancer pain.
Unfortunately many barriers regarding the use of opioids persist. Despite the changes in attitudes in the medical community, outdated rules and regulations aimed, at limiting criminal behavior, abuse and addiction, remain and propagate the legacy of fear about opioids. Patients and relatives often hamper their own treatment due to similar misconceptions about opioids, nonadherence to treatment regimens, and poor communication of their concerns. Cultural barriers and lack of knowledge are a further limiting factor for the appropriate use of opioids. Experts in the field will prepare leading articles regarding the pain classification, neuropathic pain, interventional techniques, and difficult pain syndromes. We aim to stimulate discussion by bringing together expert opinion and new science from across the field in a Special Issue of Cancers. We welcome submissions that cover relevant topics of cancer pain management.
Prof. Dr. Sebastiano Mercadante
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.